Symbols / SER $1.95 -4.41% Serina Therapeutics, Inc.

Healthcare • Biotechnology • United States • ASE
SER Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.

Fundamentals
Scroll to Statements
Market Cap 24.01M Enterprise Value 29.22M Income -19.44M Sales 130.00K Book/sh -0.46 Cash/sh 0.25
Dividend Yield — Payout 0.00% Employees — IPO — P/E — Forward P/E -1.86
PEG — P/S 184.71 P/B -4.22 P/C — EV/EBITDA -1.22 EV/Sales 224.77
Quick Ratio 0.86 Current Ratio 1.71 Debt/Eq — LT Debt/Eq — EPS (ttm) -1.91 EPS next Y -1.05
EPS Growth — Revenue Growth — Earnings 2026-03-25 ROA -219.58% ROE -81.59% ROIC —
Gross Margin 0.00% Oper. Margin -184.78% Profit Margin 0.00% Shs Outstand 12.31M Shs Float 6.84M Short Float 7.06%
Short Ratio 0.05 Short Interest — 52W High 7.92 52W Low 1.22 Beta 0.10 Avg Volume 4.62M
Volume 65.49K Target Price $11.00 Recom None Prev Close $2.04 Price $1.95 Change -4.41%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$11.00
Mean price target
2. Current target
$1.95
Latest analyst target
3. DCF / Fair value
$-16.50
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.95
Low
$11.00
High
$11.00
Mean
$11.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-08-28 reit HC Wainwright & Co. Buy → Buy $15
2025-07-14 init HC Wainwright & Co. — → Buy $15
2025-03-11 init Jones Trading — → Buy $11
News
RSS: Latest SER news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-23 MOREADITH RANDALL W. Officer — 6,500 $2.86 $18,568
2026-03-23 MOREADITH RANDALL W. Officer — 6,500 $0.06 $390
2026-03-19 MOREADITH RANDALL W. Officer — 39,000 $2.50 $97,500
2026-03-19 MOREADITH RANDALL W. Officer — 39,000 $0.06 $2,340
2026-02-02 MOREADITH RANDALL W. Officer — 6,500 $3.03 $19,680
2026-02-02 MOREADITH RANDALL W. Officer — 6,500 $0.06 $390
2026-01-28 MOREADITH RANDALL W. Officer — 6,500 $2.72 $17,680
2026-01-28 MOREADITH RANDALL W. Officer — 6,500 $0.06 $390
2026-01-22 MOREADITH RANDALL W. Officer — 2,500 $2.95 $7,375
2026-01-22 MOREADITH RANDALL W. Officer — 2,500 $0.06 $150
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
-100.00%
3.00
+500.00%
0.50
Operating Revenue
0.00
0.00
-100.00%
3.00
+500.00%
0.50
Operating Expense
24.02
+40.91%
17.05
+178.15%
6.13
+121.23%
2.77
Research And Development
13.15
+75.87%
7.48
+213.23%
2.39
+51.80%
1.57
Selling General And Administration
11.00
+14.27%
9.62
+147.15%
3.89
+202.15%
1.29
General And Administrative Expense
11.00
+14.27%
9.62
+147.15%
3.89
+202.15%
1.29
Other Gand A
11.00
+14.27%
9.62
+147.15%
3.89
+202.15%
1.29
Other Operating Expenses
-0.13
-132.14%
-0.06
+63.40%
-0.15
-67.21%
-0.09
Total Expenses
24.02
+40.91%
17.05
+178.15%
6.13
+121.23%
2.77
Operating Income
-24.02
-40.91%
-17.05
-444.84%
-3.13
-37.82%
-2.27
Total Operating Income As Reported
-24.02
-40.91%
-17.05
-444.84%
-3.13
-37.82%
-2.27
EBITDA
-18.91
-80.33%
-10.49
-277.24%
5.92
+327.14%
-2.60
Normalized EBITDA
-23.90
-1.08%
-23.64
-588.49%
4.84
+295.69%
-2.47
Reconciled Depreciation
0.07
-62.37%
0.19
+115.56%
0.09
+46.89%
0.06
EBIT
-18.98
-77.74%
-10.68
-283.30%
5.83
+318.55%
-2.67
Total Unusual Items
4.99
-62.09%
13.16
+1121.54%
1.08
+917.75%
-0.13
Total Unusual Items Excluding Goodwill
4.99
-62.09%
13.16
+1121.54%
1.08
+917.75%
-0.13
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-19.18
-72.17%
-11.14
-311.44%
5.27
+296.45%
-2.68
Pretax Income
-19.20
-71.29%
-11.21
-312.70%
5.27
+296.45%
-2.68
Net Non Operating Interest Income Expense
-0.21
+59.51%
-0.53
+5.73%
-0.56
-3851.56%
-0.01
Interest Expense Non Operating
0.21
-59.51%
0.53
-5.73%
0.56
+3414.30%
0.02
Net Interest Income
-0.21
+59.51%
-0.53
+5.73%
-0.56
-3851.56%
-0.01
Interest Expense
0.21
-59.51%
0.53
-5.73%
0.56
+3414.30%
0.02
Interest Income Non Operating
—
—
—
0.00
Interest Income
—
—
—
0.00
Other Income Expense
5.04
-20.87%
6.37
-28.91%
8.96
+2352.41%
-0.40
Other Non Operating Income Expenses
0.05
+100.75%
-6.79
-186.17%
7.88
+3062.97%
-0.27
Gain On Sale Of Security
4.99
-62.09%
13.16
+1121.54%
1.08
+917.75%
-0.13
Gain On Sale Of Business
—
—
—
0.00
Tax Provision
0.02
—
—
—
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
0.00
Tax Effect Of Unusual Items
1.05
0.00
-100.00%
0.23
0.00
Net Income Including Noncontrolling Interests
-19.21
-71.46%
-11.21
-312.70%
5.27
+296.45%
-2.68
Net Income From Continuing Operation Net Minority Interest
-19.18
-72.17%
-11.14
-311.44%
5.27
+296.45%
-2.68
Net Income From Continuing And Discontinued Operation
-19.18
-72.17%
-11.14
-311.44%
5.27
+296.45%
-2.68
Net Income Continuous Operations
-19.21
-71.46%
-11.21
-312.70%
5.27
+296.45%
-2.68
Minority Interests
0.03
-50.00%
0.07
0.00
—
Normalized Income
-23.12
+4.84%
-24.30
-649.93%
4.42
+273.23%
-2.55
Net Income Common Stockholders
-19.18
-72.17%
-11.14
-311.44%
5.27
+296.45%
-2.68
Diluted EPS
-1.91
-26.49%
-1.51
-341.13%
0.63
+150.81%
-1.23
Basic EPS
-1.91
-26.49%
-1.51
-341.13%
0.63
+150.81%
-1.23
Basic Average Shares
10.19
+38.47%
7.36
-12.54%
8.41
+286.67%
2.18
Diluted Average Shares
10.19
+38.47%
7.36
-12.54%
8.41
+11.47%
7.55
Diluted NI Availto Com Stockholders
-19.18
-72.17%
-11.14
-308.17%
5.35
+299.54%
-2.68
Average Dilution Earnings
—
0.00
-100.00%
0.08
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
6.95
+3.38%
6.72
-25.02%
8.97
+945.17%
0.86
Current Assets
6.08
+7.12%
5.68
-25.50%
7.62
+1288.87%
0.55
Cash Cash Equivalents And Short Term Investments
4.78
+30.09%
3.67
-51.80%
7.62
+1331.53%
0.53
Cash And Cash Equivalents
3.06
-16.78%
3.67
-51.80%
7.62
+1331.53%
0.53
Cash Financial
—
—
—
0.53
Other Short Term Investments
1.72
0.00
—
0.00
Receivables
—
—
—
0.00
Accounts Receivable
—
—
—
0.00
Prepaid Assets
0.99
-48.42%
1.93
—
0.02
Other Current Assets
0.31
+301.30%
0.08
—
—
Total Non Current Assets
0.87
-16.89%
1.05
-22.31%
1.35
+335.91%
0.31
Net PPE
0.84
-19.66%
1.05
-22.31%
1.35
+335.91%
0.31
Gross PPE
1.37
-16.92%
1.65
-5.18%
1.74
+156.88%
0.68
Accumulated Depreciation
-0.53
+12.15%
-0.60
-54.10%
-0.39
-6.12%
-0.37
Machinery Furniture Equipment
0.11
-17.65%
0.14
+7.94%
0.13
+19.16%
0.11
Other Properties
1.26
-16.85%
1.51
-6.20%
1.61
+182.37%
0.57
Non Current Prepaid Assets
0.03
0.00
—
—
Total Liabilities Net Minority Interest
6.99
+12.42%
6.22
-84.94%
41.26
+6.80%
38.64
Current Liabilities
3.56
+50.59%
2.37
+67.45%
1.41
+222.83%
0.44
Payables And Accrued Expenses
2.33
+77.56%
1.31
+12.64%
1.16
+646.56%
0.16
Payables
1.93
+159.54%
0.74
+28.28%
0.58
+289.64%
0.15
Accounts Payable
1.93
+159.54%
0.74
+28.28%
0.58
+304.64%
0.14
Other Payable
—
—
—
0.01
Current Accrued Expenses
0.40
-30.21%
0.57
-2.92%
0.58
+8318.77%
0.01
Pensionand Other Post Retirement Benefit Plans Current
0.81
-5.91%
0.86
—
—
Current Debt And Capital Lease Obligation
—
—
—
0.13
Current Capital Lease Obligation
—
—
—
0.13
Current Deferred Liabilities
—
—
—
0.15
Current Deferred Revenue
—
—
—
0.15
Other Current Liabilities
0.42
+120.21%
0.19
-22.80%
0.25
—
Total Non Current Liabilities Net Minority Interest
3.42
-11.04%
3.85
-90.34%
39.85
+4.32%
38.20
Long Term Debt And Capital Lease Obligation
3.14
+1072.39%
0.27
-92.22%
3.44
+105.03%
1.68
Long Term Debt
2.95
—
2.98
+84.48%
1.62
Long Term Capital Lease Obligation
0.20
-26.87%
0.27
-41.99%
0.46
+630.42%
0.06
Preferred Securities Outside Stock Equity
—
0.00
-100.00%
36.40
+2.72%
35.44
Stockholders Equity
-0.04
-105.77%
0.64
+101.98%
-32.29
+14.52%
-37.78
Common Stock Equity
-4.98
-876.44%
0.64
+101.98%
-32.29
+14.52%
-37.78
Capital Stock
4.94
+494000.00%
0.00
0.00
-100.00%
0.02
Common Stock
0.00
+0.00%
0.00
0.00
-100.00%
0.02
Preferred Stock
4.94
0.00
—
—
Share Issued
10.77
+14.28%
9.42
+11.98%
8.41
+0.00%
8.41
Ordinary Shares Number
10.77
+14.28%
9.42
+11.98%
8.41
+0.00%
8.41
Additional Paid In Capital
58.54
+30.20%
44.96
+4991.51%
0.88
+36.66%
0.65
Retained Earnings
-63.50
-43.28%
-44.32
-33.58%
-33.18
+13.71%
-38.45
Gains Losses Not Affecting Retained Earnings
-0.01
0.00
—
—
Minority Interest
0.00
+100.00%
-0.13
0.00
—
Other Equity Adjustments
-0.01
—
—
—
Total Equity Gross Minority Interest
-0.04
-107.28%
0.51
+101.57%
-32.29
+14.52%
-37.78
Total Capitalization
2.91
+353.82%
0.64
+102.19%
-29.31
+18.94%
-36.16
Working Capital
2.52
-23.96%
3.31
-46.66%
6.21
+5496.59%
0.11
Invested Capital
-2.03
-416.85%
0.64
+102.19%
-29.31
+18.94%
-36.16
Total Debt
3.14
+1072.39%
0.27
-92.22%
3.44
+90.47%
1.81
Net Debt
—
—
—
1.08
Capital Lease Obligations
0.20
-26.87%
0.27
-41.99%
0.46
+141.06%
0.19
Net Tangible Assets
-0.04
-105.77%
0.64
+101.98%
-32.29
+14.52%
-37.78
Tangible Book Value
-4.98
-876.44%
0.64
+101.98%
-32.29
+14.52%
-37.78
Derivative Product Liabilities
0.28
-92.10%
3.58
0.00
-100.00%
1.08
Interest Payable
—
0.00
—
—
Preferred Stock Equity
4.94
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-17.95
-4.77%
-17.14
-592.12%
-2.48
-19.29%
-2.08
Cash Flow From Continuing Operating Activities
-17.95
-4.77%
-17.14
-592.12%
-2.48
-19.29%
-2.08
Net Income From Continuing Operations
-19.21
-71.46%
-11.21
-312.70%
5.27
+296.45%
-2.68
Depreciation Amortization Depletion
0.07
-62.37%
0.19
+115.56%
0.09
+46.89%
0.06
Depreciation And Amortization
0.07
-62.37%
0.19
+115.56%
0.09
+46.89%
0.06
Other Non Cash Items
0.65
-11.14%
0.74
+0.55%
0.73
+393.74%
0.15
Stock Based Compensation
3.79
+46.17%
2.60
+10280.00%
0.03
+251.62%
0.01
Operating Gains Losses
-4.73
+64.05%
-13.16
-1121.54%
-1.08
-899.04%
0.13
Gain Loss On Investment Securities
-4.99
+62.09%
-13.16
-1121.54%
-1.08
-917.75%
0.13
Unrealized Gain Loss On Investment Securities
0.00
-100.00%
7.02
+192.38%
-7.60
-2944.94%
0.27
Gain Loss On Sale Of PPE
0.09
0.00
—
0.00
Change In Working Capital
1.47
+144.33%
-3.32
-4193.83%
0.08
+778.45%
-0.01
Change In Receivables
0.00
-100.00%
0.07
0.00
-100.00%
0.00
Changes In Account Receivables
—
—
—
0.00
Change In Prepaid Assets
0.67
+135.31%
-1.91
-12012.50%
0.02
+961.71%
0.00
Change In Payables And Accrued Expense
0.97
+176.61%
-1.26
-598.42%
0.25
+6602.18%
-0.00
Change In Accrued Expense
-0.23
-157.75%
0.40
+385.71%
-0.14
-4609.05%
-0.00
Change In Payable
1.20
+172.07%
-1.66
-522.65%
0.39
+42910.46%
-0.00
Change In Account Payable
1.20
+172.07%
-1.66
-522.65%
0.39
+18542.05%
-0.00
Change In Other Working Capital
—
—
—
0.15
Change In Other Current Liabilities
-0.17
+21.03%
-0.21
-13.83%
-0.19
-14.52%
-0.16
Investing Cash Flow
-0.06
-168.18%
-0.02
+95.63%
-0.50
-151.38%
0.98
Cash Flow From Continuing Investing Activities
-0.06
-168.18%
-0.02
+95.63%
-0.50
-151.38%
0.98
Net PPE Purchase And Sale
-0.06
-168.18%
-0.02
+95.63%
-0.50
-5105.54%
-0.01
Purchase Of PPE
-0.06
-168.18%
-0.02
+95.63%
-0.50
-5105.54%
-0.01
Capital Expenditure
-0.06
-168.18%
-0.02
+95.63%
-0.50
-5105.54%
-0.01
Net Investment Purchase And Sale
—
—
—
0.99
Sale Of Investment
—
—
—
0.99
Gain Loss On Sale Of Business
0.17
0.00
—
0.00
Financing Cash Flow
17.41
+31.79%
13.21
+31.24%
10.07
+667.26%
1.31
Cash Flow From Continuing Financing Activities
17.41
+31.79%
13.21
+31.24%
10.07
+667.26%
1.31
Net Issuance Payments Of Debt
4.91
+70.89%
2.88
-71.40%
10.05
+668.71%
1.31
Issuance Of Debt
4.91
+61.45%
3.04
-69.87%
10.10
+102.00%
5.00
Repayment Of Debt
0.00
+100.00%
-0.17
-250.00%
-0.05
+98.70%
-3.69
Long Term Debt Issuance
4.91
+61.45%
3.04
-69.87%
10.10
+102.00%
5.00
Long Term Debt Payments
0.00
+100.00%
-0.17
-250.00%
-0.05
+98.70%
-3.69
Net Long Term Debt Issuance
4.91
+70.89%
2.88
-71.40%
10.05
+668.71%
1.31
Net Common Stock Issuance
7.54
+50.88%
5.00
0.00
-100.00%
0.00
Proceeds From Stock Option Exercised
0.01
-99.70%
5.00
+33233.33%
0.01
—
Net Other Financing Charges
—
0.34
—
—
Changes In Cash
-0.60
+84.75%
-3.95
-155.69%
7.09
+3160.14%
0.22
Effect Of Exchange Rate Changes
-0.01
0.00
—
—
Beginning Cash Position
3.67
-51.80%
7.62
+1332.14%
0.53
+68.97%
0.31
End Cash Position
3.06
-16.78%
3.67
-51.80%
7.62
+1331.53%
0.53
Free Cash Flow
-18.01
-4.98%
-17.16
-475.81%
-2.98
-42.90%
-2.09
Interest Paid Supplemental Data
—
—
—
0.02
Common Stock Issuance
7.54
+50.88%
5.00
0.00
-100.00%
0.00
Issuance Of Capital Stock
12.48
+149.68%
5.00
0.00
-100.00%
0.00
Net Preferred Stock Issuance
4.94
0.00
—
0.00
Preferred Stock Issuance
4.94
0.00
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category